These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28449571)

  • 21. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
    Ganzini L; Heintz RT; Hoffman WF; Casey DE
    Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia and depressive illness.
    Davis KL; Berger PA; Hollister LE
    Psychopharmacol Commun; 1976; 2(2):125-30. PubMed ID: 10603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor.
    Tan EC; Chong SA; Mahendran R; Dong F; Tan CH
    Biol Psychiatry; 2001 Jul; 50(2):144-7. PubMed ID: 11526996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR; Cornes CL
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CMHC practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs.
    Benjamin S; Munetz MR
    Hosp Community Psychiatry; 1994 Apr; 45(4):343-6. PubMed ID: 7912689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Umbrich P; Soares KV
    Cochrane Database Syst Rev; 2003; (2):CD000205. PubMed ID: 12804389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
    Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Improvement of tardive dyskinesia after treatment with olanzapine].
    Truöl S; Von Hippel C; Raape J; König F
    Psychiatr Prax; 2002 Sep; 29(6):315-7. PubMed ID: 12224042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life.
    Sweet RA; Mulsant BH; Gupta B; Rifai AH; Pasternak RE; McEachran A; Zubenko GS
    Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome superimposed on tardive dyskinesia.
    Haggerty JJ; Bentsen BS; Gillette GM
    Br J Psychiatry; 1987 Jan; 150():104-5. PubMed ID: 2888500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.